文献速递临床试验与 GCP基础与转化研究

益生菌布拉氏酵母菌对多发性硬化患者心理健康、生活质量、疲劳、疼痛及炎症和氧化应激指标的影响:双盲随机对照临床试验研究方案

The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with multiple sclerosis: study protocol for a double-blind randomized controlled clinical trial.
PubMed 文献 · Trials · 2019-06-24

本研究为双盲随机对照两组平行试验,拟从门诊招募50例符合纳入标准的多发性硬化患者,随机分配接受4个月每日安慰剂或布拉氏酵母菌益生菌干预。主要终点为28项一般健康问卷评估的心理健康变化,次要终点包括生活质量、疲劳、疼痛及炎症和氧化应激指标,并记录不良事件。

要点

  • 双盲随机对照试验,50例多发性硬化患者随机接受4个月每日布拉氏酵母菌或安慰剂。
  • 主要终点为28项一般健康问卷评估的心理健康变化。
  • 次要终点包括生活质量、疲劳、疼痛及高敏C反应蛋白、丙二醛和总抗氧化能力。

核心结论

  • 该试验将收集益生菌对多发性硬化患者心理健康、生活质量、疲劳、疼痛及炎症和氧化应激指标影响的证据。
  • 原文指出需要发现管理多发性硬化症状的安全实用方法。

研究设计与样本

  • 双盲随机对照两组平行试验,从门诊招募50例符合纳入标准的多发性硬化患者。
  • 参与者随机分配接受4个月每日安慰剂或布拉氏酵母菌益生菌干预。
  • 基线和干预结束后采集血样评估炎症和氧化应激。

主要发现

  • 主要终点为28项一般健康问卷评估的心理健康变化。
  • 次要终点包括36项短表问卷评估的生活质量变化、疲劳严重程度量表评估的疲劳变化、视觉模拟量表评估的疼痛变化。
  • 次要终点还包括血清高敏C反应蛋白、丙二醛和总抗氧化能力水平变化。
  • 记录干预相关的不良事件和副作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The relationship between gut dysbiosis and inflammatory diseases including multiple sclerosis (MS) is presently recognized as an important health issue. It has been established that some bacterial probiotic strains are effective in treating MS. This study will investigate the effect of yeast probiotic Saccharomyces boulardii (SB) supplements on mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in MS patients. METHODS/DESIGN: In this double-blind randomized controlled two-group parallel trial, 50 MS patients who meet the inclusion criteria will be recruited from outpatient settings. They will be randomly allocated to 4 months of daily placebo or the SB probiotic intervention. Blood samples will be taken from each participant at the baseline and after the intervention period to assess inflammation and oxidative stress. The primary endpoint will be the changes in their mental health evaluated by the 28-item General Health Questionnaire. The secondary endpoints include changes in: (1) quality of life, evaluated by the 36-item Short Form Questionnaire, (2) fatigue, evaluated by the Fatigue Severity Scale, (3) pain, evaluated by a visual analogue scale, and (4) serum levels of indices of inflammatory stress (high-sensitivity C-reactive protein) and oxidative stress (malondialdehyde and total antioxidant capacity). Moreover, any adverse events and side effects due to the intervention will be documented. DISCUSSION: There is a need to discover safe and practical methods for managing the symptoms of MS. This trial will gather evidence on the effects of a probiotic. TRIAL REGISTRATION: Iranian Clinical Trial Registry, IRCT20161022030424N1 . Registered on 9 April 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Aghamohammadi D, Ayromlou H, Dolatkhah N, et al. The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with multiple sclerosis: study protocol for a double-blind randomized controlled clinical trial. Trials. 2019. PMID: 31234904. doi:10.1186/s13063-019-3454-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。